Tags

Type your tag names separated by a space and hit enter

Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research.
Account Res. 2005 Apr-Jun; 12(2):139-55.AR

Abstract

Financial liaisons between clinical researchers, research institutions, and industrial sponsors have gained momentum in recent years. In the process, it has been argued by many that trust in the research infrastructure is being eroded by the financial conflicts of interest that emerge from these arrangements. Yet, the financial resources of industry are needed to continue technology transfer from the bench to the bedside. Policy makers and government regulators are currently struggling to determine how to best manage financial conflicts of interest that emerge from these liaisons. Various organizations and government entities have proposed different strategies. This paper explores the limitations of existing measures and recommends that a unified national agenda is needed. We propose 10 steps to develop an agenda to address financial conflicts of interest in industry-sponsored clinical research.

Authors+Show Affiliations

Center for Biomedical Ethics, University of Virginia, School of Medicine, P.O. Box 800758, Charlottesville, VA 22908, USA. pjm7s@virginia.eduNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

16220626

Citation

Tereskerz, Patricia M., and Jonathan Moreno. "Ten Steps to Developing a National Agenda to Address Financial Conflicts of Interest in Industry Sponsored Clinical Research." Accountability in Research, vol. 12, no. 2, 2005, pp. 139-55.
Tereskerz PM, Moreno J. Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research. Account Res. 2005;12(2):139-55.
Tereskerz, P. M., & Moreno, J. (2005). Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research. Accountability in Research, 12(2), 139-55.
Tereskerz PM, Moreno J. Ten Steps to Developing a National Agenda to Address Financial Conflicts of Interest in Industry Sponsored Clinical Research. Account Res. 2005;12(2):139-55. PubMed PMID: 16220626.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Ten steps to developing a national agenda to address financial conflicts of interest in industry sponsored clinical research. AU - Tereskerz,Patricia M, AU - Moreno,Jonathan, PY - 2005/10/14/pubmed PY - 2005/12/13/medline PY - 2005/10/14/entrez KW - Biomedical and Behavioral Research SP - 139 EP - 55 JF - Accountability in research JO - Account Res VL - 12 IS - 2 N2 - Financial liaisons between clinical researchers, research institutions, and industrial sponsors have gained momentum in recent years. In the process, it has been argued by many that trust in the research infrastructure is being eroded by the financial conflicts of interest that emerge from these arrangements. Yet, the financial resources of industry are needed to continue technology transfer from the bench to the bedside. Policy makers and government regulators are currently struggling to determine how to best manage financial conflicts of interest that emerge from these liaisons. Various organizations and government entities have proposed different strategies. This paper explores the limitations of existing measures and recommends that a unified national agenda is needed. We propose 10 steps to develop an agenda to address financial conflicts of interest in industry-sponsored clinical research. SN - 0898-9621 UR - https://www.unboundmedicine.com/medline/citation/16220626/Ten_steps_to_developing_a_national_agenda_to_address_financial_conflicts_of_interest_in_industry_sponsored_clinical_research_ L2 - http://www.tandfonline.com/doi/full/10.1080/08989620590957229 DB - PRIME DP - Unbound Medicine ER -